[1]
Nanah, A. and Al Hadidi, S. 2023. Real-World Use of Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma: A Systematic Review. JAP Academy Journal. 1, 2 (Jun. 2023). DOI:https://doi.org/10.58877/japaj.v1i2.56.